LAE-32

From Wikipedia, the free encyclopedia
Jump to: navigation, search
LAE-32
LAE-32.svg
Clinical data
Synonyms LAE, Lysergic acid ethylamide, d-lysergic acid ethylamide, d-ethyllysergamide,
Routes of
administration
Oral
Pharmacokinetic data
Metabolism hepatic
Excretion renal
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C18H21N3O
Molar mass 295.378 g/mol
3D model (JSmol)
  (verify)

D-Lysergic acid ethylamide (LAE-32) is a derivative of ergine. It is reported to have some LSD-like effects but is weaker and shorter lasting, with an active dose reported to be between 0.5 and 1.5 milligrams.

It was studied by the CIA as part of Project MKULTRA. Documents published by the CIA under the Freedom of Information Act suggest it causes "a schizophrenia-like condition" but it allows people with schizophrenia to remain indifferent to their disorder.[1]

References[edit]